Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Free Cash Flow Generation Index
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of CN¥89.71 Million represents 1% of operating cash flow (CN¥110.78 Million). Read 600329 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Free Cash Flow Generation Index (2001–2024)
Historical FCF Generation Index trend for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 22 annual periods. Explore Tianjin Zhongxin Pharmaceutical Group Co (600329) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year Free Cash Flow Generation Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For the full company profile including market capitalisation, see 600329 market cap.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.87x | CN¥806.86 Million | CN¥924.67 Million | CN¥117.81 Million | ▲ +9.7% |
| 2023 | 0.80x | CN¥547.56 Million | CN¥688.49 Million | CN¥140.93 Million | ▼ -5.4% |
| 2022 | 0.84x | CN¥569.34 Million | CN¥677.25 Million | CN¥107.90 Million | ▲ +3.0% |
| 2021 | 0.82x | CN¥695.45 Million | CN¥852.40 Million | CN¥156.95 Million | ▲ +13.6% |
| 2020 | 0.72x | CN¥482.26 Million | CN¥671.42 Million | CN¥189.16 Million | ▲ +22.8% |
| 2019 | 0.59x | CN¥289.87 Million | CN¥495.49 Million | CN¥205.61 Million | ▲ +17.5% |
| 2018 | 0.50x | CN¥174.34 Million | CN¥350.14 Million | CN¥175.81 Million | ▼ -31.2% |
| 2016 | 0.72x | CN¥303.70 Million | CN¥419.90 Million | CN¥116.20 Million | ▼ -2.7% |
| 2015 | 0.74x | CN¥267.94 Million | CN¥360.58 Million | CN¥92.64 Million | ▼ -1.6% |
| 2014 | 0.76x | CN¥216.70 Million | CN¥286.85 Million | CN¥70.15 Million | ▲ +14.3% |
| 2013 | 0.66x | CN¥141.01 Million | CN¥213.44 Million | CN¥72.42 Million | ▲ +167.5% |
| 2012 | -0.98x | CN¥-20.37 Million | CN¥20.81 Million | CN¥41.18 Million | ▼ -230.0% |
| 2011 | 0.75x | CN¥130.86 Million | CN¥173.88 Million | CN¥43.02 Million | ▲ +49.0% |
| 2010 | 0.51x | CN¥70.25 Million | CN¥139.04 Million | CN¥68.79 Million | ▲ +1364.5% |
| 2009 | -0.04x | CN¥-3.33 Million | CN¥83.41 Million | CN¥86.74 Million | ▼ -105.3% |
| 2008 | 0.75x | CN¥117.40 Million | CN¥155.77 Million | CN¥38.36 Million | ▲ +145.2% |
| 2007 | -1.67x | CN¥-33.60 Million | CN¥20.13 Million | CN¥53.74 Million | ▼ -490.0% |
| 2005 | 0.43x | CN¥112.11 Million | CN¥261.91 Million | CN¥149.80 Million | ▲ +101.9% |
| 2004 | -23.04x | CN¥-241.81 Million | CN¥10.50 Million | CN¥252.31 Million | ▼ -244.1% |
| 2003 | -6.70x | CN¥-512.63 Million | CN¥76.57 Million | CN¥589.20 Million | ▼ -17523.4% |
| 2002 | 0.04x | CN¥7.21 Million | CN¥187.60 Million | CN¥180.40 Million | ▼ -74.5% |
| 2001 | 0.15x | CN¥23.77 Million | CN¥157.73 Million | CN¥133.95 Million | — |